The Metabolism Unit (MetU) at Massachusetts General Hospital is comprised of clinical investigators who conduct research on mechanisms and treatment strategies for obesity and metabolic disease. Our work has led to advances in clinical care including the development of a novel FDA-approved medication and changes to clinical practice guidelines.